The Clinical Utility and Limitations of Serum Carbohydrate Antigen (CA19-9) as a Diagnostic Tool for Pancreatic Cancer and Cholangiocarcinoma

被引：0
|
作者：
Sundeep Singh
Shou-jiang Tang
Jayaprakash Sreenarasimhaiah
Luis F. Lara
Ali Siddiqui
机构：
[1] Stanford University,Division of Gastroenterology and Hepatology
[2] University of Mississippi,Division of Digestive Diseases
[3] University of Texas-Southwestern Medical Center,Division of Digestive and Liver Diseases
[4] Baylor University Medical Center,Division of Gastroenterology and Hepatology, Jefferson Digestive Disease Institute
[5] Thomas Jefferson University,undefined
来源：
Digestive Diseases and Sciences | 2011年 / 56卷
关键词：
Serum carbohydrate antigen; CA19-9; Pancreatic cancer; Cholangiocarcinoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2491 / 2496
页数：5
相关论文
共 50 条
  • [41] Serum carcinoembryonic antigen and carbohydrate antigen 19-9 as preoperative diagnostic biomarkers of extrahepatic bile duct cancer
    Kim, Hyeong Seok
    Han, Youngmin
    Kang, Jae Seung
    Kang, Yoon Hyung
    Lee, Mirang
    Sohn, Hee Ju
    Kim, Hongbeom
    Kwon, Wooil
    Jang, Jin-Young
    BJS OPEN, 2021, 5 (06):
  • [42] Serum CA19-9 Decline Compared to Radiographic Response as a Surrogate for Clinical Outcomes in Patients With Metastatic Pancreatic Cancer Receiving Chemotherapy
    Wong, Derrick
    Ko, Andrew H.
    Hwang, Jimmy
    Venook, Alan P.
    Bergsland, Emily K.
    Tempero, Margaret A.
    PANCREAS, 2008, 37 (03) : 269 - 274
  • [43] CA19-9 AS A SCREENING AND DIAGNOSTIC-TOOL IN SYMPTOMATIC PATIENTS - THE JAPANESE EXPERIENCE
    SATAKE, K
    TAKEUCHI, T
    HOMMA, T
    OZAKI, H
    PANCREAS, 1994, 9 (06) : 703 - 706
  • [44] CA19-9, CEA and PIVKA-II as a novel panel of serum markers for diagnosis of pancreatic cancer
    Wang, Meifang
    Bu, Hongying
    Luo, Weijia
    Zeng, Xi
    Chen, Guodong
    He, Yingchun
    Cao, Deliang
    CLINICAL BIOCHEMISTRY, 2025, 137
  • [45] Combined Expression of Plasma Thrombospondin-2 and CA19-9 for Diagnosis of Pancreatic Cancer and Distal Cholangiocarcinoma: A Proteome Approach
    Le Large, Tessa Y. S.
    Meijer, Laura L.
    Paleckyte, Rosita
    Boyd, Lenka N. C.
    Kok, Bart
    Wurdinger, Thomas
    Schelfhorst, Tim
    Piersma, Sander R.
    Pham, Thang V.
    Grieken, Nicole C. T.
    Zonderhuis, Barbara M.
    Daams, Freek
    van Laarhoven, Hanneke W. M.
    Bijlsma, Maarten F.
    Jimenez, Connie R.
    Giovannetti, Elisa
    Kazemier, Geert
    ONCOLOGIST, 2020, 25 (04) : E634 - E643
  • [46] CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort
    Marta Herreros-Villanueva
    Lourdes Ruiz-Rebollo
    Mario Montes
    Mario Rodriguez-Lopez
    María Francisco
    Joaquín Cubiella
    Eduardo Iyo
    Emilio Garabitos
    Emma Martínez Moneo
    Maider Martos
    Enrique de Madaria
    Ibon Martínez-Arránz
    Marta García-Cougil
    Agueda Iglesias-Gómez
    Luis Bujanda
    Molecular Biology Reports, 2020, 47 : 1583 - 1588
  • [47] CA19-9 capability as predictor of pancreatic cancer resectability in a Spanish cohort
    Herreros-Villanueva, Marta
    Ruiz-Rebollo, Lourdes
    Montes, Mario
    Rodriguez-Lopez, Mario
    Francisco, Maria
    Cubiella, Joaquin
    Iyo, Eduardo
    Garabitos, Emilio
    Martinez Moneo, Emma
    Martos, Maider
    de Madaria, Enrique
    Martinez-Arranz, Ibon
    Garcia-Cougil, Marta
    Iglesias-Gomez, Agueda
    Bujanda, Luis
    MOLECULAR BIOLOGY REPORTS, 2020, 47 (03) : 1583 - 1588
  • [48] Diagnostic value of preoperative serum carcinoembryonic antigen and carbohydrate antigen 19-9 in colorectal cancer
    Polat, E.
    Duman, U.
    Duman, M.
    Atici, A. E.
    Reyhan, E.
    Dalgic, T.
    Bostanci, E. B.
    Yol, S.
    CURRENT ONCOLOGY, 2014, 21 (01) : E1 - E7
  • [49] CA19-9:: A pedictor of response in pancreatic cancer treated with gemcitabine and cisplatin
    Heinemann, V
    Schermuly, MM
    Stieber, P
    Schulz, L
    Jüngst, D
    Wilkowski, R
    Schalhorn, A
    ANTICANCER RESEARCH, 1999, 19 (4A) : 2433 - 2435
  • [50] Prognostic impact of the ratio of preoperative CA19-9 to liver enzyme levels in pancreatic cancer patients with jaundice (predictability of combined CA19-9/AST and CA19-9/γ-GGT for jaundiced PDAC patients)
    Huang, Xumin
    Lu, Zipeng
    Zhang, Kai
    Wang, Guangfu
    Cai, Baobao
    Wu, Pengfei
    Yin, Jie
    Miao, Yi
    Jiang, Kuirong
    PANCREATOLOGY, 2021, 21 (06) : 1092 - 1101
12345